Metabonomic Evaluation of Schaedler Altered Microflora Rats
|
|
- Merryl O’Neal’
- 6 years ago
- Views:
Transcription
1 1388 Chem. Res. Toxicol. 2007, 20, Metabonomic Evaluation of Schaedler Altered Microflora Rats Cynthia M. Rohde,*, Dale F. Wells, Lora C. Robosky, Matthew L. Manning, Charles B. Clifford, Michael D. Reily, and Donald G. Robertson Metabonomics EValuation Group, Pfizer Global Research and DeVelopment, 2800 Plymouth Road, Ann Arbor, Michigan 48105, and Charles RiVer Laboratories, 251 BallardVale Street, Wilmington, Massachusetts ReceiVed May 25, 2007 Downloaded via on June 30, 2018 at 19:44:43 (UTC). See for options on how to legitimately share published articles. Previously, we identified two distinct metabonomic phenotypes in Sprague Dawley rats sourced from two different rooms (colonies) in the Charles River, Raleigh facility [Robosky, L. C., Wells, D. F., Egnash, L. A., Manning, M. L., Reily, M. D., and Robertson, D. G. (2005) Metabonomic identification of two distinct phenotypes in Sprague Dawley (Crl:CD(SD)) rats. Toxicol. Sci. 87, ]. On the basis of literature reports and cohabitation experiments, we concluded that the differing phenotypes were due to different gut flora populations. One hypothesis explaining this phenomenon was attributed to the practice of initiating new colonies with rats derived from foundation colonies that had limited gut floral populations, the Charles River altered Schaedler flora (CRASF) rats. We hypothesized that the lack of differentiation of CRASF rats to the full complement of microflora was responsible for the altered phenotype characterized by increased urinary chlorogenic acid metabolites and decreased hippurate (CA rats) as opposed to the prevalent phenotype characterized by the inverse ratio of these metabolites (HIP rats). Upon receipt, it was confirmed that the CRASF rats exhibited a metabonomic profile similar to CA rats that remained constant while animals were housed individually in a dedicated animal room. However, exposure of CRASF rats to HIP rats, or their bedding, led to a relatively rapid but variable rate of reversion to the historic HIP type metabolic profile. On the basis of the results, we conclude that CRASF rats have a unique metabolic profile due to their limited gut flora constitution. If rigorous isolation procedures are not employed, the CRASF phenotype will eventually differentiate into the more typical HIP phenotype with a time course that may be quite variable. Given the marked metabolic heterogeneity between the phenotypes, this work highlights the importance of monitoring rat metabolic profiles. Introduction Humans, as well as other mammals, contain large microbial populations on the skin, in the mouth, in the genital area, and in the gastrointestinal (GI) 1 tract. The majority of these bacteria, approximately 10 13, reside in the GI tract (2). The full complement of this microflora population is acquired shortly after birth but is adjusted throughout life depending on such factors as antibiotic administration, infection, stress, hygiene, and diet ( 3 6). These gut flora have coevolved with their hosts and play a vital role in a number of mammalian processes including the immune response, intestinal development and health, and metabolism of nutrients and drugs/toxins (2, 7 11). Because of their involvement in these various activities, differences in these microflora populations may be a source of interanimal variation in safety assessment studies (11, 12). Recently, two distinct phenotypes of Sprague Dawley rats, originating from the Charles River Raleigh Facility, were discovered by examination of urinary metabolite profiles (1). One phenotype, designated HIP, was characterized by high hippurate and low chlorogenic acid metabolite levels, while the second phenotype, designated CA, exhibited the inverse ratio of these urinary metabolites. The HIP rats represent the conventional metabonomic phenotype for Sprague Dawley rats * To whom correspondence should be addressed. Tel: rohdec@wyeth.com. Pfizer Global Research and Development. Charles River Laboratories. 1 Abbreviations: CRASF, Charles River altered Schaedler flora; GI, gastrointestinal; PCA, principal component analysis. typically determined in our laboratory. Literature reports (13, 14) and a cohabitation experiment (1) suggested that the difference in the two phenotypes was due to differing gut flora populations between CA and HIP rats. This postulated variation in gut flora in the two colonies could be explained by a difference in the rate of conventionalization of gut microorganisms. When a new production colony of Sprague Dawley rats is initiated at Charles River Laboratories, a specific process is followed. The new colony is seeded using foundation colony rats, which have a specific complement of gut flora. In the case of the Sprague Dawley rats, the altered Schaedler flora population of bacteria is used and the foundation colony rats are referred to as Charles River altered Schaedler flora (CRASF) rats (15, 16). Over time, the foundation rats in the new production colony acquire a full complement of gut bacterial species. As the previously described CA rats came from a production colony initiated in December 2002, as opposed to the HIP rats whose colony was formed in March 2000 or earlier, we postulated that the CA rats had not yet fully converted to the conventional gut flora population. Therefore, the following study was performed to determine if the CRASF rats were the source of the CA phenotype. Materials and Methods Animals. CRASF rats, approximately 6 8 weeks old and g, were graciously supplied by Charles River Laboratories (Wilmington, MA). Routine Animal Husbandry. Animals were housed in an AAALAC-accredited facility, and all in-life studies were reviewed /tx700184u CCC: $ American Chemical Society Published on Web 09/28/2007
2 Communications Chem. Res. Toxicol., Vol. 20, No. 10, and approved by IACUC. Animals were housed in temperature (70 78 C) and humidity (30 70% relative humidity) controlled rooms with a 12 h light cycle throughout the study. Animals were fed Certified Rodent Chow 5002 (Laboratory Diet, Purina Mills, Richmond, IN) and provided with drinking water ad libitum throughout the study. When urine was not being collected, animals were housed in individual cages. Study Timeline. Immediately upon arrival, CRASF rats, six males and six females, were placed in an isolated animal room, where they remained for 10 days. Urine was collected for 24 h periods for the first 3 days after receipt of the animals and once at the end of the 10 days. After approximately 10 days in the isolated animal room, animals were moved to a room containing a stock colony of HIP phenotype Sprague Dawley rats. The CRASF rats were placed in individual hanging stainless steel cages in a cage rack directly below stock colony rats, and routine animal husbandry practices were employed taking no special precautions to prevent cross-contamination of the two phenotypes. CRASF rats were handled (for daily clinical procedures) in numerical order (1 12) after handling of the HIP phenotype rats. Urine was subsequently collected approximately once a week for the subsequent 39 days after the transfer to the stock colony. Beginning on day 50, rats still exhibiting the original Schaedler urinary metabolic profile were exposed to bedding from standard stock colony animals for 4 days. Urine samples were collected daily during this time. Urine Collection. When urine was collected, animals were placed in individual metabolism cages (Harvard Apparatus, Holliston, MA). Except for the first urine collection, which was begun immediately upon receipt, animals were acclimated to metabolism cages for 24 h prior to urine collection. Urine was collected into chilled (0 C) tubes containing a total of 1 ml of 1% sodium azide. After the collection was complete, samples were spun down (3000 rpm, 4 C) for 10 min to remove particulate matter. Samples were then either immediately analyzed or stored at approximately -70 C until NMR analysis. One-Dimensional 1 H NMR Spectroscopy. Urine samples were prepared for NMR analysis as previously described (1). Briefly, urine was diluted 2:1 with normalization buffer [0.2 M sodium phosphate buffer, ph 7.4 (80:20 H 2 O:D 2 O), 1 mm TSP, 3 mm sodium azide] in a 96 well format. Plates were mixed and centrifuged before analyzing. 1 H NMR spectra were acquired using a Varian Inova NMR spectrophotometer operating at MHz for 1 H and equipped with a 1 H-[ 15 N, 13 C] flow cryoprobe and a Varian automated transport accessory. The probe was washed twice with buffer [(2:1) water:0.2 M sodium phosphate buffer, ph 7.4] between each sample. One-dimensional 1 H NMR spectra were acquired at 27 C using a one-dimensional NOESY pulse sequence including water presaturation and a mixing time of 100 ms. A total of 64 scans were collected with 64K data points, an acquisition time of 2.73 s, an interpulse delay of 1 s, and a sweep width of 12 khz. NMR Data Analysis. Spectra were processed using 1 Hz line broadening and integrated over 0.04 ppm regions (or bins) from 0.2 to 10 ppm using either Bruker s Amix software or our internal Matlab processing package. The water-containing region from 4.5 to 6 ppm was excluded in further analyses. Principal components analysis (PCA) was completed using Pirouette software, version 3.02 (Infometrix, Inc., Bothell, WA), for calculation and Spotfire DecisionSite 8.1 software (Spotfire, Inc., Somerville, MA) for visualization. The PCA map was compiled using the full NMR data set for the CRASF (isolated) male rats from days 3 and 5 out of the six CRASF (exposed to stock colony) male rats from day 53. Also included in the PCA analysis were NMR spectral data taken from CA (n ) 10) and HIP (n ) 8) male rats in May Results Urine NMR spectra (Figure 1) and PCA analysis (Figure 2) from the initial 3 days in the animal facility showed that the CRASF phenotype was similar, but not identical, to the CA phenotype. The CRASF rats had similar hippurate levels to CA Figure 1. Representative urinary NMR spectra of HIP, CRASF (exposed to stock colony), CRASF (isolated), and CA male rats. The region shown is from 8.2 to 6.6 ppm. Individual CRASF (isolated) and CRASF (exposed to stock colony) urinary spectra were chosen from rats on days 3 and 53, respectively. Individual urinary NMR spectra of HIP and CA male rats are from data obtained in May Only representative samples from male rats are shown, but female rats exhibited a similar pattern. Resonances for hippurate and phenylacetylglycine are indicated on the spectra. Resonances for 3-(3- hydroxyphenyl)propionic acid and 3-(4-hydroxyphenyl)propionic acid are marked on the spectra as 1 and 2, respectively. Figure 2. PCA map of HIP, CRASF (exposed to stock colony), CRASF (isolated), and CA rats. Each phenotype is indicated as follows: HIP (triangles), CRASF (exposed to stock colony; stars), CRASF (isolated; squares), and CA (circles). For the CRASF (exposed to stock colony) rats, only the five male rats that were fully converted on day 53 were used in the analysis. Only male rats were used in the PCA analysis, but female rats showed a similar pattern. rats but slightly lower levels of chlorogenic acid metabolites as compared to CA rats (Table 1). There were also slight differences in other metabolites, such as phenylacetylglycine (Table 1). This CRASF phenotype was stable over the course of 10 days, while the rats were maintained in an isolated animal room. After 10 days in isolation, CRASF rats were transferred to a room containing stock colony rats, which exhibit the HIP phenotype by both NMR spectra (Figure 1) and PCA analysis (Figure 2). Seven days after the transfer, all of the CRASF rats still maintained their original urinary metabolite profile. However, 13 days after the transfer to the stock colony, the first rat to be handled after stock colony rats during routine husbandry
3 1390 Chem. Res. Toxicol., Vol. 20, No. 10, 2007 Communications Table 1. Relative Levels of Various Urinary Metabolites from HIP, CA, CRASF (Isolated), and CRASF (Exposed to Stock Colony) Rats a HIP CA CRASF (isolated) CRASF (exposed to stock colony) hippurate N-methylnicotinamide (3-hydroxyphenyl)propionic acid 3-(4-hydroxyphenyl)propionic acid phenylacetylglycine a Levels of all metabolites were acquired and normalized as described in the Materials and Methods. The group average for each metabolite for each phenotype was then divided by the group average for each metabolite for the HIP phenotype. Group averages for metabolite levels for HIP and CA rats were obtained from data obtained in May Group averages for metabolite levels for CRASF (isolated) rats were obtained from data acquired on day 11 and for CRASF (exposed to stock colony rats) on day 53. Figure 3. Change in hippurate levels in individual CRASF rats over the course of the experiment. Hippurate levels were quantitated from NMR spectra using Metabonomi software, as described in the Materials and Methods, for each urine collection. (A) Individual male rat hippurate levels. (B) Individual female rat hippurate levels. (rat 1) was found to have a phenotype similar to HIP rats (Figures 1 and 2). The urinary hippurate levels had increased, while the chlorogenic acid metabolites had decreased. After 21 days in the stock colony, another male (rat 2), in the cage adjacent to the first converted animal, switched to a phenotype similar to HIP rats. By the 28th day in the stock colony, three rats had spontaneously converted to a phenotype similar to HIP rats, two males (rats 1 and 2) and one female (rat 7). The timeline of this conversion can easily be observed by tracking the hippurate levels of each rat over time (Figure 3). After 35 days in the stock colony, one male rat (rat 3) had partially changed to the new phenotype. So, rats were being conventionalized, but only gradually. To see if the conversion could be accelerated by exposure to HIP rat fecal material, two male (rats 4 and 5) and three female rats (rats 8 10), which still maintained the CRASF phenotype, were exposed to bedding from HIP rats and monitored daily for phenotype changes beginning on day 50. With this exposure, one male (rat 4) and all three females (rats 8 10) exposed to the HIP bedding quickly converted to the urinary metabolite profile similar to HIP rats (Figure 2). The second male rat (rat 5) exposed to HIP bedding did not convert but did show an increase in hippurate levels by the fourth day of exposure (Figure 3). During this exposure period, the two female rats (rats 11 and 12) not given HIP bedding maintained the CRASF phenotype, while the remaining CRASF male rat (rat 6) spontaneously converted to a new phenotype (Figure 3). Discussion This communication provides evidence that the differences observed in the urinary metabolite profiles of HIP and CA rats are due to variations in their respective microflora populations caused by differential acquisition of normal gut flora after stock colony initiation from CRASF rats. The first piece of data to support this hypothesis is that the main differences between the two urinary metabolite profiles, CA and HIP, are alterations in the hippurate and chlorogenic acid metabolite levels. Both hippurate and chlorogenic acid derivatives are produced via metabolism of polyphenols, compounds commonly found in fruits, vegetables, and cereals (Figure 4) (17, 18). Metabolism of these compounds is mainly accomplished by gut flora, although certain steps, such as glycine conjugation, are performed by the mammalian host system (Figure 4) (18, 19). It remains unclear which bacteria are responsible for each specific reaction that occurs during the breakdown of polyphenolic compounds in vivo, but it has previously been shown that multiple species of microflora are required to produce the full complement of metabolites found in the urine of conventionalized rats (20, 21). Therefore, changes in the microflora population may alter the types of reactions that can be performed, modify the metabolite profile, and potentially limit or enhance the bioavailability of various ingested compounds. Further support for the hypothesis comes from other studies in the literature where changes were observed in the urinary levels of hippurate and chlorogenic acid metabolites in cases where differences in gut flora populations occurred (13, 14, 22, 23). In these studies, the intestinal bacteria population was altered by using germ-free rats vs conventionalized, adjusting the diet of the animals, or treating the animals with different compounds. Additionally, the urinary metabolite profile of isolated CRASF rats, which are used to seed new colonies of Sprague Dawley rats at Charles River Laboratories, most closely resembles that of the CA rats as opposed to the HIP rats. Finally, CRASF rats exposed to either a HIP stock colony environment or directly to HIP rat bedding relatively rapidly acquire a urinary metabolic profile consistent with HIP rats. All of these results suggest that the CA rats have yet to acquire the full complement of microflora demonstrated by the conventional HIP rats. It is unclear why the metabolic profile of exposed CRASF rats differs from HIP rats. It is possible that the exposed CRASF rat profile is a transient state due to repopulating gut flora that may revert to the typical HIP phenotype over longer periods of time (>50 days) or perhaps the change reflects the fact that CRASF rats never fully become the HIP phenotype over their individual life spans but eventually conventionalize over
4 Communications Chem. Res. Toxicol., Vol. 20, No. 10, Figure 4. Metabolism of chlorogenic acid. Chlorogenic acid is the most abundant polyphenol in the human diet. After ingestion, chlorogenic acid can be metabolized via intestinal bacteria to either quinic acid or caffeic acid, eventually leading to the production of hippurate or phenylpropionic acid derivatives. Reactions that are performed by gut flora are highlighted by a bold arrow, while reactions that are done by the mammalian host system are indicated by a thin arrow. repeated generations. It also remains unclear why the CA rats documented in our first report (1) did not develop the conventional complement of gut flora within the 3 year period from colony initiation. In several cases where germ-free or low hippurate-excreting rats were exposed to a standard stock colony environment, rats achieved a conventional urinary metabolite profile after only 21 days (19, 22, 23). This gut flora acclimation occurs even more rapidly when rats are housed with high hippurate-excreting rats ( 1, 22). However, if the CA rats were not exposed to a HIP environment, with the exacting husbandry techniques practiced in today s animal facilities, it is possible that only slight changes in the microflora environment of the CA rats may have occurred, leading to a urinary profile very similar to the original CRASF foundation rats. These data, taken together, emphasize the importance of microflora in the determination of the overall metabolic phenotype of the host animal. The types of bacteria living in the GI tract in combination with host metabolism ultimately determine the metabolic fate of an ingested compound, whether it is a normal component of the diet or an exogenous material such as a drug or toxin. This means that differences in gut flora populations can influence how an individual animal responds to a particular stimulus, a potential source for interanimal variation. Therefore, screening of populations for phenotypic metabolic differences should be considered as these differences may influence the results of research investigations, especially safety assessment studies. This source of variation also needs to be taken into account when considering the concept of personalized health care, as has been previously noted (11, 24 26). In conclusion, the urinary metabolite profile of CRASF rats maintained in an isolated environment is similar to that of CA rats. When CRASF rats are housed in a room with HIP rats, their metabonomic phenotype gradually changes to one that closely resembles that of the HIP rats. Exposure to HIP bedding greatly accelerates this conversion process. The phenotypic differences between the CA and the HIP rats appear to be due to alterations in the gut flora populations, most likely due to a slow rate of microflora conventionalization in the CA colony. Although it would be interesting to further explore the differences between the HIP and the CA rats, especially with respect to how their differences might affect drug metabolism, the CA rats are no longer available. The CA rats, as recently reported, have now reverted to the HIP phenotype (27). References (1) Robosky, L. C., Wells, D. F., Egnash, L. A., Manning, M. L., Reily, M. D., and Robertson, D. G. (2005) Metabonomic identification of two distinct phenotypes in Sprague Dawley (Crl:CD(SD)) rats. Toxicol. Sci. 87, (2) Sears, C. L. (2005) A dynamic partnership: Celebrating our gut flora. Anaerobe 11, (3) Alverdy, J., Zaborina, O., and Licheng, W. (2005) The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr. Opin. Clin. Nutr. Metab. Care 8, (4) Collins, M. D., and Gibson, G. R. (1999) Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut. Am. J. Clin. Nutr. 69, 1052S 1057S. (5) Hawrelak, J. A., and Myers, S. P. (2004) The causes of intestinal dysbiosis: A review. Altern. Med. ReV. 9, (6) Mai, V. (2004) Dietary modification of the intestinal microbiota. Nutr. ReV. 62, (7) Hooper, L. V., Midtvedt, T., and Gordan, J. I. (2002) How hostmicrobial interactions shape the nutrient environment of the mammalian intestine. Annu. ReV. Nutr. 22, (8) Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., and Gordan, J. I. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, (9) Kelly, D., Conway, S., and Aminov, R. (2005) Commensal gut bacteria: Mechanisms of immune modulation. Trends Immunol. 26, (10) Mikov, M. (1994) The metabolism of drugs by gut flora. Eur. J. Drug Metab. Pharmacokinet. 19, (11) Nicholson, J. K., Holmes, E., and Wilson, I. D. (2005) Gut microorganisms, mammalian metabolism and personalized health care. Nat. ReV. Miocrobiol. 3,
5 1392 Chem. Res. Toxicol., Vol. 20, No. 10, 2007 Communications (12) Li, H., Ni, Y., Su, M., Qiu, Y., Zhou, M., Qiu, M., Zhao, A., Zhao, L., and Jia, W. (2007) Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats. J. Proteome Res. 6, (13) Gavaghan, C. L., Nicholson, J. K., Connor, S. C., Wilson, I. D., Wright, B., and Holmes, E. (2001) Directly coupled high-performance liquid chromatography and nuclear magnetic resonance spectroscopic with chemometric studies on metabolic variation in Sprague Dawley rats. Anal. Biochem. 291, (14) Phipps, A. N., Stewart, J., Wright, B., and Wilson, I. D. (1998) Effect of diet on the urinary excretion of hippuric acid and other dietaryderived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28, (15) Dewhirst, F. E., Chien, C. C., Paster, B. J., Ericson, R. L., Orcutt, R. P., Schauer, D. B., and Fox, J. G. (1999) Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl. EnViron. Microbiol. 65, (16) Sarma-Rupavtarm, R. B., Ge, Z., Schauer, D. B., Fox, J. G., and Polz, M. F. (2004) Spatial distribution and stability of the eight microbial species of the altered Schaedler flora in the mouse gastrointestinal tract. Appl. EnViron. Microbiol. 70, (17) Gonthier, M. P., Verny, M. A., Besson, C., Remesy, C., and Scalbert, A. (2003) Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 133, (18) Manach, C., Scalbert, A., Morand, C., Remesy, C., and Jimenez, L. (2004) Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 79, (19) Goodwin, B. L., Ruthven, C. R., and Sandler, M. (1994) Gut flora and the origin of some urinary aromatic phenolic compounds. Biochem. Pharmacol. 47, (20) Peppercorn, M. A., and Goldman, P. (1971) Caffeic acid metabolism by bacteria of the human gastrointestinal tract. J. Bacteriol. 108, (21) Peppercorn, M. A., and Goldman, P. (1972) Caffeic acid metabolism by gnotobiotic rats and their intestinal bacteria. Proc. Natl. Acad. Sci. U.S.A. 69, (22) Williams, R. E., Eyton-Jones, H. W., Farnworth, M. J., Gallagher, R., and Provan, W. M. (2002) Effect of intestinal microflora on the urinary metabolic profile of rats: A 1 H-nuclear magnetic resonance spectroscopy study. Xenobiotica 32, (23) Nicholls, A. W., Mortshire-Smith, R. J., and Nicholson, J. K. (2003) NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, (24) Clayton, T. A., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J. P., Le Net, J. L., Baker, D., Walley, R. J., Everett, J. R., and Nicholson, J. K. (2006) Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440, (25) Goodacre, R. (2007) Metabolomics of a superorganism. J. Nutr. 137, 259S 266S. (26) Nebert, D. W., and Vesell, E. S. (2006) Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics. Trends Pharmacol. Sci. 27, (27) Robosky, L. C., Wells, D. F., Egnash, L. A., Manning, M. L., Reily, M. D., and Robertson, D. G. (2006) Communication regarding metabonomic identification of two distinct phenotypes in Sprague Dawley (Crl:CD(SD)) rats. Toxicol. Sci. 91, 309. TX700184U
Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids
Metabolomica Analisi di biofluidi mediante spettroscopia NMR Michael Assfalg Università di Verona Terminology Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids
More informationUrinary metabolic profiling in inflammatory bowel disease. Dr Horace Williams Clinical Research Fellow Imperial College London
Urinary metabolic profiling in inflammatory bowel disease Dr Horace Williams Clinical Research Fellow Imperial College London Background: Metabolic profiling Metabolic profiling or metabonomics describes
More informationNMR for Metabolomics
NMR for Metabolomics NMR spectroscopy for metabonomic studies the quantitative measurement of the multi-parametric metabolic response of living systems to pathophysiological stimuli or genetic modification
More informationDiet, Microbiome and Health Cindy D. Davis
Diet, Microbiome and Health Cindy D. Davis davisci@mail.nih.gov OFFICE OF DIETARY SUPPLEMENTS 1 Outline 1.What is the microbiome? 2.How does it vary over the lifespan? 3.What is the evidence that diet
More informationTerminology. Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids
Terminology Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids Metabolome: the quantitative complement of all the low molecular weight molecules present in
More informationThe number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells.
The number of microorganisms residing in our intestines is 10 times the number of our somatic and germ cells. The number of microorganisms residing in our intestines is 10 times the number of our somatic
More informationThe Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain
The Gut Microbiota: Evidence For Gut Microbes as Contributors to Weight Gain Michael T. Bailey, Ph.D. Center for Microbial Pathogenesis The Research Institute, Nationwide Children s Hospital Department
More informationGut microflora and estrogens: a new paradigm for breast cancer risk reduction. Dr. Kathleen Egan (Moffitt) Dr. Lusine Yaghjyan (UF)
Gut microflora and estrogens: a new paradigm for breast cancer risk reduction Dr. Kathleen Egan (Moffitt) Dr. Lusine Yaghjyan (UF) Background Approximately 100 trillion microorganisms live in our bodies
More informationH-NMR METABOLOMIC ANALYSIS OF THE EFFECTS OF PROBIOTICS ADMINISTRATION ON HUMAN METABOLIC PHENOTYPE (on going) Probiota 2016 Dr.
1 H-NMR METABOLOMIC ANALYSIS OF THE EFFECTS OF PROBIOTICS ADMINISTRATION ON HUMAN METABOLIC PHENOTYPE (on going) Probiota 2016 Dr. Marco Pane Microbiota genome change over time Trends Microbiol. 2012
More informationMetabolic profiling study of ketoprofen-induced toxicity using 1 H NMR spectroscopy coupled with multivariate analysis
Journal of the Korean Magnetic Resonance Society 2011, 15, 54-68 DOI : 10.6564/JKMRS.2011.15.1.054 Metabolic profiling study of ketoprofen-induced toxicity using 1 H NMR spectroscopy coupled with multivariate
More informationReduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats
Microbiol. Immunol. Vol. 21 (9), 495-503, 1977 Reduction of Population Levels of Some Indigenous Bacteria by Lactobacilli in the Gastrointestinal Tract of Gnotobiotic Rats Tsugio WATANABE, Masami MOROTOMI,
More informationAN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z
AN ACUTE ORAL TOXICITY STUDY IN RATS WITH ADVANTRA Z AMENDED FINAL REPORT Author Deborah A Douds, M.S. Original Study Completion Date July 8, 1997 Amended Study Completion Date November 19, 1997 Performing
More informationThe METAM-02 clinical study was a San Raffaele Institutional Review Board-approved
SUPPLEMENTARY METHODS Page 1 of 9 Clinical Study The METAM-02 clinical study was a San Raffaele Institutional Review Board-approved prospective, single-arm, observational monocentric trial, aimed at investigating
More informationINSIDER S GUIDE Organic Acids: Dysbiosis By Ron Grisanti, D.C. & Dicken Weatherby, N.D.
Functional Medicine University s Functional Diagnostic Medicine Training Program INSIDER S GUIDE Organic Acids: Dysbiosis By Ron Grisanti, D.C. & Dicken Weatherby, N.D. http://www.functionalmedicineuniversity.com
More informationM I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION
M I C R O B I O L O G Y WITH DISEASES BY TAXONOMY, THIRD EDITION Chapter 14 Infection, Infectious Diseases, and Epidemiology Lecture prepared by Mindy Miller-Kittrell, University of Tennessee, Knoxville
More informationGut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI
Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human
More informationMetabonomics and MRS BCMB/CHEM 8190
Metabonomics and MRS BCMB/CHEM 8190 Metabolomics, Metabonomics, Metabolic Profiling! Definition: The quantitative measurement of the dynamic multi parametric metabolic response of living systems to physiological
More informationSTEPS to better gut health
5 STEPS to better gut health More than 2000 years ago, the renowned Greek Physician Hippocrates and Father of Medicine said... Let Food be Your Medicine & Medicine be Your Food. His words of wisdom are
More informationGut Microbiome Essentials
CORE COMPONENTS I: Gut Microbiome Essentials 2016 Tom Fabian, PhD Module Outline 1. Microbiome overview: getting a sense of the microbiome, research, what we know 2. Bacteria: features, functions, communities
More informationInvestigation of the Confinement Odour Problem in Exported Lamb using NMRbased
Investigation of the Confinement Odour Problem in Exported Lamb using NMRbased Metabolomics A thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Chemistry
More informationGlutathione Assay Kit
Glutathione Assay Kit Catalog Number KA1649 250 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of the Assay...
More informationPhD student Gregorio Peron e-mail: gregorio.peron@studenti.unipd.it tel.: 347 4802865 Proposed supervisor Dott. Stefano Dall Acqua e-mail: stefano.dallacqua@unipd.it tel.: 049 8275332 Project title English:
More informationPROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT PROBIOTICS: WHAT ARE THEY, AND HOW DO THEY WORK? Karen Jensen, (Retired ND)
PROBIOTICS: WHO S WHO AND WHAT S WHAT IN THE GUT Karen Jensen, (Retired ND) Today many people are aware of the benefits of maintaining a healthy gut. As a result, probiotic use is becoming ever more popular.
More informationOverview of the Microbiome in Health and Disease Cindy D. Davis
Overview of the Microbiome in Health and Disease Cindy D. Davis davisci@mail.nih.gov OFFICE OF DIETARY SUPPLEMENTS 1 Outline 1.What is the microbiome? 2.What is the evidence that diet can influence the
More informationINTRODUCING YOUR GUT BACTERIA
INTRODUCING YOUR GUT BACTERIA Microflora Intestinal flora 1.5 kg We would die with 5 years of birth if we did not have them as we would not develop a proper immune system 1000 species and 5000 strains
More informationINTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES
EXAMPLES OF INDIVIDUAL ANALYSES INTESTINAL MICROBIOTA Microbiota in the animal or human intestine has evolved together with the host. Consequently, the gastrointestinal tract could be considered a metacommunity,
More informationEffect of dietary fiber on intestinal gas production and small bowel transit time in man13
ffect of dietary fiber on intestinal gas production and small bowel transit time in man13 John H. Bond,4 M.D. and Michael D. Levitt,5 M.D. ABSTRACT The influence of dietary fiber on intestinal gas production
More informationProbiotics. NOW Guide to Probiotics
Probiotics NOW Guide to Probiotics The Health Benefits of Probiotics Microorganisms for Health Did you know that you have trillions of microorganisms, including bacteria and yeast, living in and on your
More informationchapter 1 - fig. 2 Mechanism of transcriptional control by ppar agonists.
chapter 1 - fig. 1 The -omics subdisciplines. chapter 1 - fig. 2 Mechanism of transcriptional control by ppar agonists. 201 figures chapter 1 chapter 2 - fig. 1 Schematic overview of the different steps
More informationModule Four: The GI System Module Five: The Gut Microbiome. The GI System. LLiana Shanti, CN
Module Four: The GI System Module Five: The Gut Microbiome The GI System LLiana Shanti, CN www.healthmasteryinstitute.com Review Review Review The Gut Hippocrates has been quoted as saying death sits in
More informationNormal Flora. CLS 212: Medical Microbiology
Normal Flora CLS 212: Medical Microbiology Relationships between Organisms Symbiosis Permanent association between two different organisms. Neutralism Two organisms living together, and neither is affected
More informationMetabolic classification of herb plants by NMR-based metabolomics
Journal of the Korean Magnetic Resonance Society 2012, 16, 91-102 Metabolic classification of herb plants by NMR-based metabolomics Hee-Eun Kim, 1,a Ye Hun Choi, 2,a Kwang-Ho Choi, 1,a Ji Su Park, 2 Hyeon
More informationMark Manary MD. International Symposium on Understanding Moderate Malnutrition in Children for Effective Interventions
Possible role of the microbiome in the development of acute malnutrition and implications for food-based strategies to prevent and treat acute malnutrition International Symposium on Understanding Moderate
More information1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h.
1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h. 2. The waste is then stored for 2 days in the large bowel. 3. Do modern humans need a large bowel?
More informationExamining the effects of pre and probiotics on gut microbiota during the ageing process
Session: Reviewing key ingredients shaping nutrition for healthy ageing Tuesday 22 nd November 2016 Examining the effects of pre and probiotics on gut microbiota during the ageing process Louise R Wilson
More informationPresented by Megan R. Sanctuary, MS University of California at Davis
Effects of supplementation with Bifidobacterium infantis in combination with bioactive milk components on gastrointestinal symptoms in children with autism Presented by Megan R. Sanctuary, MS University
More informationCalf Notes.com. Calf Note #155 Day 2. Introduction
Calf Notes.com Calf Note #155 Day 2 Introduction Calf nutrition and management seems to be divided into two distinct periods namely, the first day of life and everything after. We all know of the importance
More informationBibliografia Microbiota
Bibliografia Microbiota Systematic Review: Gut Microbiota in Fecal Samples and Detection of Colorectal Neoplasms. The role of the intestinal microbiome in ocular inflammatory disease. The gut microbiome
More information12/1/2017. Disclosures. Objectives. The Microbiome Defined
Can Critical Illness and the Microbiome Play Nice Together? SCOTT BOLESTA, PHARMD, BCPS, FCCM ASSOCIATE PROFESSOR OF PHARMACY PRACTICE, WILKES UNIVERSITY VISITING INVESTIGATOR, GEISINGER HEALTH SYSTEM
More informationInfluence of acute phytochemical intake on human urinary metabolomic profiles 1 3
Influence of acute phytochemical intake on human urinary metabolomic profiles 1 3 Marianne C Walsh, Lorraine Brennan, Estelle Pujos-Guillot, Jean-Louis Sébédio, Augustin Scalbert, Ailís Fagan, Desmond
More informationMicrobiome in You: Optimizing Gut Bacteria for Better IBD Management
Microbiome in You: Optimizing Gut Bacteria for Better IBD Management KT Park, M.D., M.S. Assistant Professor Co-Director, Stanford Children s Inflammatory Bowel Disease Center Stanford University School
More informationPage 1132
Page 1131 Page 1132 Page 1133 Page 1134 Page 1135 Huntingdon Life Sciences 03-6140 Page 6. Final Report TABLE OF CONTENTS Page 1136 COVER PAGE...1 GLP STATEMENT...2 SIGNATURE PAGE...3 QUALITY ASSURANCE
More informationEnhancing Bioavailability of Nutrients
Round Table Enhancing Bioavailability of Nutrients Yrjö H. Roos 1 April 2013 ESPCA/São Paulo School of Advanced Science Advances in Molecular Structuring of Food Materials Faculty of Animal Science and
More informationIII. TOXICOKINETICS. Studies relevant to the toxicokinetics of inorganic chloramines are severely
III. TOXICOKINETICS Introduction Studies relevant to the toxicokinetics of inorganic chloramines are severely limited. However, studies done with various chlorinated amino compounds (including organic
More informationOBESITY AND THE CONNECTION TO THE GUT
OBESITY AND THE CONNECTION TO THE GUT Weight Loss Most weight loss programs are based on calorie in = calorie out Does not matter how they are dressed up Most of these plans being healthier foods to people
More informationManipulating the gut microbiome
Manipulating the gut microbiome William DePaolo, PhD Associate Professor Medicine Director Center for Microbiome Sciences & Therapeutics University of Washington Microbiota The actual bugs that reside
More informationLactobacillus bulgaricus
probiotic Lactobacillus bulgaricus Danone " : : * * * * * Bifidobacterium (LactobacillusCG) (Saccharomyce) (Bifidobacterium) (Antibiotic related diarrhea) GG L (Cytoprotection) B IgA lgg Probiotics -
More informationTHE MISSING PIECE IN AUTISM DIAGNOSIS: COULD WE BE OVERLOOKING THE GUT MICROBIOME?
THE MISSING PIECE IN AUTISM DIAGNOSIS: COULD WE BE OVERLOOKING THE GUT MICROBIOME? ALTERNATIVEMEDICINE.COM SUBCONSCIOUS SUGGESTION: WE TRY HYPNOTHERAPY The Color Run: 5 TIPS TO BEAT THE BUGS HORSES THAT
More informationGut Reaction. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Gut Reaction Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Ley, R. et al (2005) PNAS vol. 102 no. 31 Bacterial diversity in the distal gut (ceca) of C57BL6 mice. (A) Phylogenetic tree of
More informationProbiotics for Primary Prevention of Clostridium difficile Infection
Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss
More informationHygiene Hypothesis: 10 years later. Christina Ciaccio MD, MSc Assistant Professor The University of Chicago
Hygiene Hypothesis: 10 years later Christina Ciaccio MD, MSc Assistant Professor The University of Chicago none Disclosures Definitions Microbe: Microscopic organism Microbiota: Microbial community Definition
More informationMicrobiology With Diseases by Taxonomy
Microbiology With Diseases by Taxonomy Second Edition PowerPoint Lecture Slides 14 Infection, Infectious Diseases, and Epidemiology SARS: Severe Acute Respiratory Syndrome 2003 Chapter opener 14 Chapter
More informationThe Urinary System. Lab Exercise 38. Objectives. Introduction
Lab Exercise The Urinary System Objectives - Be able to identify the structures of the urinary system and give their function - Be able to recognize the gross anatomy of the kidney - Identify the components
More informationThe impact of high fat dietinduced gut microbiota on circadian rhythm and obesity
The impact of high fat dietinduced gut microbiota on circadian rhythm and obesity Vanessa A. Leone, Ph.D. Postdoctoral scholar Impact of circadian dysrhythmia in gastrointestinal diseases Circadian rhythms
More information9/8/17. Reducing Inflammation + Supporting the Immune System. Module #2 Fighting Inflammation
Reducing Inflammation + Supporting the Immune System 1 Table of Contents Module 1: What is Inflammation? Inflammatory markers Signs and symptoms Chronic disease risk Module 2: Fighting Inflammation Acidity/alkalinity
More informationSchool of Chemistry, Food and Pharmacy, The University of Reading, Whiteknights, Reading, RG6
Variation in antibiotic-induced microbial recolonization impacts on the host metabolic phenotypes of rats 1,2* Jonathan R. Swann, 2 Kieran M. Tuohy, 2 Peter Lindfors, 2 Duncan T. Brown, 2 Glenn R. Gibson,
More informationGut Inflammation: Effects on Animal Production and Management Approaches
Gut Inflammation: Effects on Animal Production and Management Approaches Carrie Cook, Ph.D., Aova Technologies, Inc. The more we learn about inflammation, the more it captures a key role in our understanding
More informationThe Gut Microbiome: 101 Justin Carlson University of Minnesota
The Gut Microbiome: 101 Justin Carlson University of Minnesota Where are we now? 360 B.C. 2003 Human Gut Microbes Associated With Obesity Ley et al., Nature. 2006. Consumer Driven Science For Better of
More informationSZ Tan ST4 Ophthalmology MREH
* SZ Tan ST4 Ophthalmology MREH *Metabolomics is the study/ quantification of endogenous and exogenous metabolites in biological systems Genes define the potential of what may happen and metabolites define
More informationFructose Assay Kit. Catalog Number KA assays Version: 02. Intended for research use only.
Fructose Assay Kit Catalog Number KA1668 100 assays Version: 02 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...
More informationUnderstanding probiotics and health
Understanding probiotics and health Gemma Laws MSc Student Microbiology and Immunology Department The gut microbiota The name given to the total microbial population living in our intestine Bacteria, fungi,
More informationEFFECTS OF ALETA IN PROMOTING THE GROWTH OF PROBIOTIC BACTERIA: IN VITRO STUDY
2 Senoko Drive 758 200 Singapore tel: +65.6755.633 www.kemin.com EFFECTS OF ALETA IN PROMOTING THE GROWTH OF PROBIOTIC BACTERIA: IN VITRO STUDY Lakshmibai Vasanthakumari Bindhu. Ph.D Abstract: It is well
More informationThe effect of probiotics on animal health: a focus on host s natural intestinal defenses
The effect of probiotics on animal health: a focus on host s natural intestinal defenses Guillaume Tabouret Animal Health Dept. Joint Unit 1225 Host Pathogens Interactions History of probiotics and definition
More informationSurvival of Aerobic and Anaerobic Bacteria in
APPLIED MICROBIOLOGY, Mar. 1968, p. 445-449 Copyright 1968 American Society for Microbiology Vol. 16, No. 3 Printed in U.S.A. Survival of Aerobic and Anaerobic Bacteria in Chicken Meat During Freeze-Dehydration,
More informationDetectX. Urinary Creatinine Detection Kit. Catalog Number K002-H1. Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine
World s Only One Component Assay Simple & Easy to Use DetectX Urinary Creatinine Detection Kit Catalog Number K002-H1 Sample Types Validated: Human, Monkey, Dog, Rat and Mouse Urine Please read this insert
More informationMade available courtesy of Nature Publishing Group: ***Note: Figures may be missing from this format of the document
Gut microbiota: a potential new territory for drug targeting By: Wei Jia, Houkai Li, Liping Zhao and Jeremy K. Nicholson Jia, W., Li, H., Zhao, L., Nicholson, J.K. (2008) Gut microbiota: a potential new
More informationThe Potential For Microbiome Modification In Critical Illness. Deborah Cook
The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to
More informationMegaSporeBiotics Probiotics. Linda Wilbert - Stewart, FDN, HHP, HC 1/28/
MegaSporeBiotics Probiotics www.exclusivelyholistic.com Linda Wilbert - Stewart, FDN, HHP, HC 1/28/2015 111 MegaSporeBiotic is the first, all spore, carotenoid rich, probiotic consortium formulation on
More informationDieta mediterranea e Nutraceutica per la cura delle dislipidemie e la prevenzione cardiovascolare
Dieta mediterranea e Nutraceutica per la cura delle dislipidemie e la prevenzione cardiovascolare Lecce, 27 maggio 2017 Polo Universitario ECOTEKNE dell Università degli Studi di Lecce Via per Monteroni
More informationSupplementary Information: Liquid-liquid phase coexistence in lipid membranes observed by natural abundance 1 H 13 C solid-state NMR
Electronic Supplementary Material (ESI) for Physical Chemistry Chemical Physics. This journal is the wner Societies 28 Supplementary Information: Liquid-liquid phase coexistence in lipid membranes observed
More informationHEPARIN SODIUM. Heparinum natricum
Pharmeuropa 25.1 1 Reference: PA/PH/Exp. 6/T (12) 37 ANP NOTE ON THE MONOGRAPH Definition. It is proposed to restrict the scope to heparin material of porcine origin since some of the latest requirements
More informationFructose Assay Kit. Catalog Number KA assays Version: 03. Intended for research use only.
Fructose Assay Kit Catalog Number KA1668 100 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 General Information...
More informationGCSE Food Technology (AQA) Food safety and hygiene
GCSE Food Technology (AQA) Food safety and hygiene Food spoilage Food spoilage Food products can t be stored for a long time without changes taking place. The changes that often occur are to the taste,
More informationIrritable Bowel Syndrome Causes and Treatments
Irritable Bowel Syndrome Causes and Treatments Oh heck. Gas, bloating, alternating constipation and diarrhea, food cravings and abdominal pain. Your symptoms may be significant and cause you embarrassment
More informationShotgun metaproteomics of the human distal gut microbiota. Present by Lei Chen
Shotgun metaproteomics of the human distal gut microbiota Present by Lei Chen (lc6@indana.edu) Outline Background What are the goals? Materials and Methods Results Discussion Background The human gastrointestinal
More informationMALDI Sepsityper Kit
Instructions for Use MALDI Sepsityper Kit Kit for identification of microorganisms from positive blood cultures using the MALDI Biotyper system CARE products are designed to support our worldwide customers
More informationBringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute
Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Jennifer T. Smilowitz, PhD Associate Director, Human Studies Research jensm@ucdavis.edu
More informationGoing With Your Gut: The Microbiome and You
Going With Your Gut: The Microbiome and You Robert T. Schooley, MD Professor of Medicine University of California San Diego San Diego, California Learning Objectives After attending this presentation,
More informationChoosing the metabolomics platform
Choosing the metabolomics platform Stephen Barnes, PhD Department of Pharmacology & Toxicology University of Alabama at Birmingham sbarnes@uab.edu Challenges Unlike DNA, RNA and proteins, the metabolome
More informationChapter 1. Introduction
Chapter 1 Introduction 1.1 Motivation and Goals The increasing availability and decreasing cost of high-throughput (HT) technologies coupled with the availability of computational tools and data form a
More informationInfluence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 657-663 http://www.ijcmas.com Original Research Article Influence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens Anayata Sharma 1*
More informationGut Lung Axis Implication of the Gut Microbiota beyond its niche
Gut Lung Axis Implication of the Gut Microbiota beyond its niche Reema Subramanian PhD Candidate (4 th year) Supervisor: Prof. Margaret Ip Department of Microbiology, CUHK Joint Graduate Student Seminar
More informationThe role of nutrition in optimum gastrointestinal health
The role of nutrition in optimum gastrointestinal health Kelly A. Tappenden, Ph.D., R.D., FASPEN Kraft Foods Human Nutrition Endowed Professor University Distinguished Teacher-Scholar University of Illinois
More informationDISCUSSION GROUP #5 ISAPP 2014 THE MICROBIOME AND HEALTH: PROMISING ENDPOINTS FOR INTERVENTIONS. Friday, June 20, 2014
DISCUSSION GROUP #5 ISAPP 2014 THE MICROBIOME AND HEALTH: PROMISING ENDPOINTS FOR INTERVENTIONS Friday, June 20, 2014 Chairs: George Fahey, Jens Walter 1 What do we want to achieve? Treatment of disease
More informationMicrobiome. A new dimension in Medicine. Israel De Alba, MD MPH. Clinical Professor
Microbiome A new dimension in Medicine Israel De Alba, MD MPH Clinical Professor AIM To look at ordinary things from a different perspective.to jump start curiosity Reason to have lunch We know so much
More informationGRANT TITLE: NON ANTIBIOTIC ALTERNATIVES FOR THE PREVENTION AND TREATMENT OF URINARY TRACT INFECTIONS FOLLOWING SCI.
GRANT TITLE: NON ANTIBIOTIC ALTERNATIVES FOR THE PREVENTION AND TREATMENT OF URINARY TRACT INFECTIONS FOLLOWING SCI. Todd A. Linsenmeyer, MD Director of Urology Kessler Institute of Rehabilitation Pleasant
More informationAcute Oral Toxicity Study in Rats with Argentyn 23 (EPA/OECD Guidelines) Study Title. Monica M. Vegarra, BS. Sponsor
Note: This study was done using our Professional strength 23 ppm product (Argentyn 23), therefore making Sovereign Silver at 10 ppm, 2.3 times safer. Conclusion on page 6 shows the product to be non-toxic
More informationCANDIDIASIS AND LEAKY GUT PROTOCOLS
CANDIDIASIS AND LEAKY GUT PROTOCOLS The Goal of Candidiasis Protocol Candidiasis refers to yeast overgrowth The key to this protocol is inhibiting the yeast to make it easier for the good bacteria to regain
More informationNovel method of probiotic administration
Novel method of probiotic administration Multifactorial Prematurity Low birth weight Enteral feeds Altered intestinal microflora microflora Infants that develop NEC have changes in microbial community:
More informationL. E. Phillip, M.V. Simpson, E. S. Idziak H and S.F. Kubow*
Ruminal and metabolic effects of pure lignin in sheep fed low and high fibre diets. L. E. Phillip, M.V. Simpson, E. S. Idziak H and S.F. Kubow* Introduction Previous studies with cattle indicated that
More informationIntroduction to MUN. What is Urea
Introduction to MUN What is Urea Urea is a small organic molecule composed of carbon, nitrogen, oxygen, and hydrogen. Urea is a common constituent of blood and other body fluids. Urea is formed from ammonia
More informationIntroduction onto a metabonomic study of peri-parturient dairy goats Ana Elena Cismileanu 1, Celine Domange 2
Introduction onto a metabonomic study of peri-parturient dairy goats Ana Elena Cismileanu 1, Celine Domange 2 1 National Research Institute for Animal Biology and Nutrition Balotesti (IBNA), Balotesti,
More informationSeppo Salminen Mimi Tang
Koletzko B. (ed): Pediatric Nutrition in Practice. Basel, Karger, 2008, pp 80 84 1 General Aspects of Childhood Nutrition 1.8 Gut Microbiota in Infants Seppo Salminen Mimi Tang Key Words M i c r o b i
More informationBiacid: A EU approved natural growth promoter for Broilers
Biacid is a blend of calcium salts of organic acids and essential oils. Through the optimal combination of calcium salts of organic acids and essential oils, it enhances broiler microflora within the gut
More informationTerminology. Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids
Terminology Metabolite: substance produced or used during metabolism such as lipids, sugars and amino acids A metabolite may be described as a compound which is internalized, chemically converted or secreted
More informationPowerPoint Presentation Gut microbiome and diet By Professor Elizabeth Shephard, PhD
0:04 Slide #1 Good afternoon. Thank you for inviting me to join you in MEBO Miami Meetup. 0:12 I'm Elizabeth Shepard, and today I will introduce how the gut microbiome and diet are relevant to those who
More informationSupporting Information for:
Supporting Information for: Methylerythritol Cyclodiphosphate (MEcPP) in Deoxyxylulose Phosphate Pathway: Synthesis from an Epoxide and Mechanisms Youli Xiao, a Rodney L. Nyland II, b Caren L. Freel Meyers
More informationSarkis K Mazmanian, California Institute of Technology
Sarkis K Mazmanian, California Institute of Technology The human microbiota The human gut harbors 10 11-10 12 bacteria per gram colonic content (>10 14 total bacteria) Total bacteria outnumber human cells
More informationSupporting Information (SI)
Electronic Supplementary Material (ESI) for Analyst. This journal is The Royal Society of Chemistry 2015 Supporting Information (SI) Title: Optimization of Metabolite Extraction of Human Vein Tissue for
More informationComparative Efficacy of Peroxyacetic Acid and Sodium Hypochlorite Bleach against Enterobacteria, E. coli and Yeasts Molds on Cherries
Comparative Efficacy of Peroxyacetic Acid and Sodium Hypochlorite Bleach against Enterobacteria, E. coli and Yeasts Molds on Cherries Purpose The primary purpose of this study was to determine whether
More information